Stockreport

BriaCell Announces Six Clinical Data Presentations at ASCO 2026

BriaCell Therapeutics Corp. - Common Shares  (BCTX) 
PDF Final randomized Phase 2 Bria-IMT™ survival and quality of life data to be presentedBiomarker analyses from the ongoing Phase 3 study evaluating predictors of response [Read more]